PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
0.7460
-0.0060 (-0.80%)
At close: Jul 15, 2026, 4:00 PM EDT
0.7311
-0.0149 (-2.00%)
After-hours: Jul 15, 2026, 6:30 PM EDT
PDS Biotechnology Market Cap
PDS Biotechnology has a market cap or net worth of $41.64 million as of July 15, 2026. Its market cap has decreased by -31.51% in one year.
Market Cap
41.64M
Enterprise Value
35.69M
1-Year Change
-31.51%
Ranking
Category
Stock Price
$0.75
Market Cap Chart
Since March 18, 2019, PDS Biotechnology's market cap has decreased from $45.51M to $41.64M, a decrease of -8.51%. That is a compound annual growth rate of -1.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 41.64M | -1.15% |
| Dec 31, 2025 | 42.12M | -30.92% |
| Dec 31, 2024 | 60.98M | -60.56% |
| Dec 29, 2023 | 154.61M | -58.92% |
| Dec 30, 2022 | 376.31M | 63.37% |
| Dec 31, 2021 | 230.35M | 383.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hyperion DeFi | 45.62M |
| Dyadic International | 43.36M |
| Apollomics | 40.30M |
| CervoMed | 40.17M |
| Grace Therapeutics | 39.79M |
| NanoViricides | 39.58M |
| Actuate Therapeutics | 39.48M |
| RenovoRx | 39.17M |